Literature DB >> 17276105

Mobility in patients with venous leg ulceration.

M Clarke-Moloney1, A Godfrey, V O'Connor, H Meagher, P E Burke, E G Kavanagh, P A Grace, G M Lyons.   

Abstract

OBJECTIVES: To compare mobility in patients with venous leg ulcers to matched controls and determine the influence of mobility, age and ulcer size on ulcer healing.
METHODS: 25 leg ulcer patients, and 25 matched controls wore a mobility monitor (ActivPAL, PAL Technologies Ltd, Glasgow, Scotland)) which recorded the number of steps and amount of time spent walking, standing, sitting or lying for a one-week period. A walking index was calculated. The ulcer group were treated with compression bandaging and ulcer healing recorded over 12 weeks.
RESULTS: There were 13 female subjects in each group. The median age was 70.5 (range 30-89) years. There was no difference in the amount of time either group spent standing, walking and resting. There was a significant reduction in the number of steps taken and in the walking index in the ulcer group compared to controls (ulcer group, median 6,685 steps/day, range 2074-17,999; control group median 8750, range 4917-16,043, p<0.05, Mann Whitney u test). Smaller ulcers and ulcers of recent onset were most likely to heal within 12 weeks (p=0.005 and p=0.011 respectively, Chi squared test). The percentage of time spent mobilising and resting did not influence ulcer healing (r(s)=-0.125; p=0.55).
CONCLUSIONS: Mobility patterns among patients with leg ulcers are not significantly different to age matched controls. Ulcer patients take fewer steps per week compared to controls indicating they have reduced calf muscle pump function. Further studies are required to determine whether therapies which increase calf muscle activity have a role in ulcer treatment.

Entities:  

Mesh:

Year:  2007        PMID: 17276105     DOI: 10.1016/j.ejvs.2006.11.032

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  6 in total

1.  Clinically Recognized Varicose Veins and Physical Function in Older Individuals: The ARIC Study.

Authors:  Yejin Mok; Junichi Ishigami; Yingying Sang; Anna M Kucharska-Newton; Maya Salameh; Jennifer A Schrack; Priya Palta; Josef Coresh; B Gwen Windham; Pamela L Lutsey; Aaron R Folsom; Kunihiro Matsushita
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-08-12       Impact factor: 6.591

2.  A randomised controlled 8-week crossover clinical evaluation of the 3M Coban 2 Layer Compression System versus Profore to evaluate the product performance in patients with venous leg ulcers.

Authors:  Christine J Moffatt; Lynfa Edwards; Mark Collier; Terry Treadwell; Michael Miller; Laura Shafer; Gary Sibbald; Alain Brassard; Andrea McIntosh; Alex Reyzelman; Patricia Price; Stacia Merkel Kraus; Shelley-Ann Walters; Keith Harding
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

3.  Instrumenting gait with an accelerometer: a system and algorithm examination.

Authors:  A Godfrey; S Del Din; G Barry; J C Mathers; L Rochester
Journal:  Med Eng Phys       Date:  2015-03-04       Impact factor: 2.242

Review 4.  Measuring Activity Performance of Older Adults Using the activPAL: A Rapid Review.

Authors:  Charice S Chan; Susan E Slaughter; C Allyson Jones; Carla Ickert; Adrian S Wagg
Journal:  Healthcare (Basel)       Date:  2017-12-13

5.  Ethnic differences in sedentary behaviour in 6-8-year-old children during school terms and school holidays: a mixed methods study.

Authors:  Liana C Nagy; Maria Horne; Muhammad Faisal; M A Mohammed; Sally E Barber
Journal:  BMC Public Health       Date:  2019-02-04       Impact factor: 3.295

6.  Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU).

Authors:  Andrew Jull; Angela Wadham; Chris Bullen; Varsha Parag; John G M Parsons; George Laking; Jill Waters; Markos Klonizakis; Jane O'Brien
Journal:  BMJ Open       Date:  2021-02-18       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.